首页 > 最新文献

Journal of Anesthesia, Analgesia and Critical Care (Online)最新文献

英文 中文
Perfusion deficits may underlie lung and kidney injury in severe COVID-19 disease: insights from a multicenter international cohort study. 灌注缺陷可能是严重 COVID-19 疾病造成肺和肾损伤的原因:一项多中心国际队列研究的启示。
Pub Date : 2024-07-06 DOI: 10.1186/s44158-024-00175-1
Alice Nova, Bairbre McNicholas, Aurora Magliocca, Matthew Laffey, Vanessa Zambelli, Ilaria Mariani, Minahel Atif, Matteo Giacomini, Giovanni Vitale, Roberto Rona, Giuseppe Foti, John Laffey, Emanuele Rezoagli

Background: Lung perfusion defects, mainly due to endothelial and coagulation activation, are a key contributor to COVID-19 respiratory failure. COVID-19 patients may also develop acute kidney injury (AKI) because of renal perfusion deficit. We aimed to explore AKI-associated factors and the independent prediction of standardized minute ventilation (MV)-a proxy of alveolar dead space-on AKI onset and persistence in COVID-19 mechanically ventilated patients.

Methods: This is a multicenter observational cohort study. We enrolled 157 COVID-19 patients requiring mechanical ventilation and intensive care unit (ICU) admission. We collected clinical information, ventilation, and laboratory data. AKI was defined by the 2012 KDIGO guidelines and classified as transient or persistent according to serum creatinine criteria persistence within 48 h. Ordered univariate and multivariate logistic regression analyses were employed to identify variables associated with AKI onset and persistence.

Results: Among 157 COVID-19 patients on mechanical ventilation, 47% developed AKI: 10% had transient AKI, and 37% had persistent AKI. The degree of hypoxia was not associated with differences in AKI severity. Across increasing severity of AKI groups, despite similar levels of paCO2, we observed an increased MV and standardized MV, a robust proxy of alveolar dead space. After adjusting for other clinical and laboratory covariates, standardized MV remained an independent predictor of AKI development and persistence. D-dimer levels were higher in patients with persistent AKI.

Conclusions: In critically ill COVID-19 patients with respiratory failure, increased wasted ventilation is independently associated with a greater risk of persistent AKI. These hypothesis-generating findings may suggest that perfusion derangements may link the pathophysiology of both wasted ventilation and acute kidney injury in our population.

背景:主要由内皮和凝血活化引起的肺灌注缺陷是导致 COVID-19 呼吸衰竭的关键因素。COVID-19 患者还可能因肾脏灌注不足而发生急性肾损伤(AKI)。我们旨在探索 AKI 相关因素以及标准化分钟通气量(MV)--肺泡死腔的代表--对 COVID-19 机械通气患者 AKI 发生和持续的独立预测:这是一项多中心观察性队列研究。我们招募了 157 名需要机械通气并入住重症监护室(ICU)的 COVID-19 患者。我们收集了临床信息、通气和实验室数据。根据 2012 年 KDIGO 指南对 AKI 进行了定义,并根据 48 小时内血清肌酐标准的持续性将其分为一过性和持续性:在 157 名接受机械通气的 COVID-19 患者中,47% 出现了 AKI:10% 为一过性 AKI,37% 为持续性 AKI。缺氧程度与 AKI 严重程度的差异无关。在 AKI 严重程度不断增加的各组中,尽管 paCO2 水平相似,但我们观察到肺活量和标准化肺活量(肺泡死腔的可靠代表)增加。在对其他临床和实验室协变量进行调整后,标准化肺活量仍然是 AKI 发生和持续的独立预测因子。持续性 AKI 患者的 D-二聚体水平较高:结论:在 COVID-19 呼吸衰竭的重症患者中,虚脱通气量的增加与持续性 AKI 的更高风险独立相关。这些假设性发现可能表明,在我们的人群中,灌注失调可能与通气量减少和急性肾损伤的病理生理学有关。
{"title":"Perfusion deficits may underlie lung and kidney injury in severe COVID-19 disease: insights from a multicenter international cohort study.","authors":"Alice Nova, Bairbre McNicholas, Aurora Magliocca, Matthew Laffey, Vanessa Zambelli, Ilaria Mariani, Minahel Atif, Matteo Giacomini, Giovanni Vitale, Roberto Rona, Giuseppe Foti, John Laffey, Emanuele Rezoagli","doi":"10.1186/s44158-024-00175-1","DOIUrl":"10.1186/s44158-024-00175-1","url":null,"abstract":"<p><strong>Background: </strong>Lung perfusion defects, mainly due to endothelial and coagulation activation, are a key contributor to COVID-19 respiratory failure. COVID-19 patients may also develop acute kidney injury (AKI) because of renal perfusion deficit. We aimed to explore AKI-associated factors and the independent prediction of standardized minute ventilation (MV)-a proxy of alveolar dead space-on AKI onset and persistence in COVID-19 mechanically ventilated patients.</p><p><strong>Methods: </strong>This is a multicenter observational cohort study. We enrolled 157 COVID-19 patients requiring mechanical ventilation and intensive care unit (ICU) admission. We collected clinical information, ventilation, and laboratory data. AKI was defined by the 2012 KDIGO guidelines and classified as transient or persistent according to serum creatinine criteria persistence within 48 h. Ordered univariate and multivariate logistic regression analyses were employed to identify variables associated with AKI onset and persistence.</p><p><strong>Results: </strong>Among 157 COVID-19 patients on mechanical ventilation, 47% developed AKI: 10% had transient AKI, and 37% had persistent AKI. The degree of hypoxia was not associated with differences in AKI severity. Across increasing severity of AKI groups, despite similar levels of paCO<sub>2</sub>, we observed an increased MV and standardized MV, a robust proxy of alveolar dead space. After adjusting for other clinical and laboratory covariates, standardized MV remained an independent predictor of AKI development and persistence. D-dimer levels were higher in patients with persistent AKI.</p><p><strong>Conclusions: </strong>In critically ill COVID-19 patients with respiratory failure, increased wasted ventilation is independently associated with a greater risk of persistent AKI. These hypothesis-generating findings may suggest that perfusion derangements may link the pathophysiology of both wasted ventilation and acute kidney injury in our population.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141545625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative fluid management is not predictive of AKI in major pancreatic surgery: a retrospective cohort study. 术中液体管理不能预测胰腺大手术中的 AKI:一项回顾性队列研究。
Pub Date : 2024-07-02 DOI: 10.1186/s44158-024-00176-0
Kerri Lydon, Saurin Shah, Kai L Mongan, Paul D Mongan, Michael Calvin Cantrell, Ziad Awad

Background: Pancreatic surgery is associated with a significant risk for acute kidney injury (AKI) and clinically relevant postoperative pancreatic fistula (CR-POPF). This investigation evaluated the impact of intraoperative volume administration, vasopressor therapy, and blood pressure management on the primary outcome of AKI and the secondary outcome of a CR-POPF after pancreatic surgery.

Methods: This retrospective single-center cohort investigated 200 consecutive pancreatic surgeries (January 2018-December 2021). Patients were categorized for the presence/absence of AKI (Kidney Disease Improving Global Outcomes) and CR-POPF. After univariate analysis, multivariable models were constructed to control for the univariate cofactor differences in the primary and secondary outcomes.

Results: AKI was identified in 20 patients (10%) with significant univariate differences in demographics (body mass index and gender), comorbidities, indices of chronic renal insufficiency, and an increased AKI Risk score. Surgical characteristics, intraoperative fluid, vasopressor, and blood pressure management were similar in patients with and without AKI. Patients with AKI had increased blood loss, lower urine output, and packed red blood cell administration. After multivariate analysis, male gender (OR = 7.9, 95% C.I. 1.8-35.1) and the AKI Risk score (OR = 6.3, 95% C.I. 2.4-16.4) were associated with the development of AKI (p < 0.001). Intraoperative and postoperative volume, vasopressor administration, and intraoperative hypotension had no significant impact in the multivariate analysis. CR-POPF occurred in 23 patients (11.9%) with no significant contributing factors in the multivariate analysis. Patients who developed AKI or a CR-POPF had an increase in surgical complications, length of stay, discharge to a skilled nursing facility, and mortality.

Conclusion: In this analysis, intraoperative volume administration, vasopressor therapy, and a blood pressure < 55 mmHg for more than 10 min were not associated with an increased risk of AKI. After multivariate analysis, male gender and an elevated AKI Risk score were associated with an increased likelihood of AKI.

背景:胰腺手术与急性肾损伤(AKI)和临床相关的术后胰瘘(CR-POPF)的重大风险相关。这项研究评估了术中容量管理、血管加压疗法和血压管理对胰腺手术后急性肾损伤(AKI)这一主要结果和胰腺瘘(CR-POPF)这一次要结果的影响:该回顾性单中心队列调查了 200 例连续胰腺手术(2018 年 1 月至 2021 年 12 月)。患者根据有/无 AKI(肾病改善全球结果)和 CR-POPF 进行分类。在进行单变量分析后,构建了多变量模型,以控制主要和次要结果中的单变量辅因子差异:结果:20 名患者(10%)出现了 AKI,这些患者在人口统计学(体重指数和性别)、合并症、慢性肾功能不全指数和 AKI 风险评分增加方面存在显著的单变量差异。有 AKI 和无 AKI 患者的手术特征、术中输液、血管抑制剂和血压管理相似。有 AKI 的患者失血量增加,尿量减少,需要使用包装红细胞。经过多变量分析,男性(OR = 7.9,95% C.I.,1.8-35.1)和 AKI 风险评分(OR = 6.3,95% C.I.,2.4-16.4)与 AKI 的发生有关(p 结论:AKI 的发生与患者的性别和年龄有关:在这项分析中,术中给药量、血管加压疗法和血压计(OR = 6.3)均与 AKI 的发生有关。
{"title":"Intraoperative fluid management is not predictive of AKI in major pancreatic surgery: a retrospective cohort study.","authors":"Kerri Lydon, Saurin Shah, Kai L Mongan, Paul D Mongan, Michael Calvin Cantrell, Ziad Awad","doi":"10.1186/s44158-024-00176-0","DOIUrl":"10.1186/s44158-024-00176-0","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic surgery is associated with a significant risk for acute kidney injury (AKI) and clinically relevant postoperative pancreatic fistula (CR-POPF). This investigation evaluated the impact of intraoperative volume administration, vasopressor therapy, and blood pressure management on the primary outcome of AKI and the secondary outcome of a CR-POPF after pancreatic surgery.</p><p><strong>Methods: </strong>This retrospective single-center cohort investigated 200 consecutive pancreatic surgeries (January 2018-December 2021). Patients were categorized for the presence/absence of AKI (Kidney Disease Improving Global Outcomes) and CR-POPF. After univariate analysis, multivariable models were constructed to control for the univariate cofactor differences in the primary and secondary outcomes.</p><p><strong>Results: </strong>AKI was identified in 20 patients (10%) with significant univariate differences in demographics (body mass index and gender), comorbidities, indices of chronic renal insufficiency, and an increased AKI Risk score. Surgical characteristics, intraoperative fluid, vasopressor, and blood pressure management were similar in patients with and without AKI. Patients with AKI had increased blood loss, lower urine output, and packed red blood cell administration. After multivariate analysis, male gender (OR = 7.9, 95% C.I. 1.8-35.1) and the AKI Risk score (OR = 6.3, 95% C.I. 2.4-16.4) were associated with the development of AKI (p < 0.001). Intraoperative and postoperative volume, vasopressor administration, and intraoperative hypotension had no significant impact in the multivariate analysis. CR-POPF occurred in 23 patients (11.9%) with no significant contributing factors in the multivariate analysis. Patients who developed AKI or a CR-POPF had an increase in surgical complications, length of stay, discharge to a skilled nursing facility, and mortality.</p><p><strong>Conclusion: </strong>In this analysis, intraoperative volume administration, vasopressor therapy, and a blood pressure < 55 mmHg for more than 10 min were not associated with an increased risk of AKI. After multivariate analysis, male gender and an elevated AKI Risk score were associated with an increased likelihood of AKI.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study. 将有核红细胞作为 SARS-CoV-2 引起的 ARDS 患者死亡率的预后指标:一项观察性研究。
Pub Date : 2024-06-28 DOI: 10.1186/s44158-024-00174-2
Anna Kirsch, Felix Niebhagen, Miriam Goldammer, Sandra Waske, Lars Heubner, Paul Petrick, Andreas Güldner, Thea Koch, Peter Spieth, Mario Menk

Background: The presence of nucleated red blood cells (NRBCs) in the peripheral blood of critically ill patients is associated with poor outcome. Evidence regarding the predictive value of NRBCs in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) remains elusive. The aim of this study was to evaluate the predictive validity of NRBCs in these patients.

Methods: Daily NRBC values of adult patients with SARS-CoV-2-induced ARDS were assessed and their predictive validity for mortality was statistically evaluated. A cut-off level based on the patient's maximum NRBC value during ICU stay was calculated and further specified according to Youden's method. Based on this cut-off value, further analyses such as logistic regression models and survival were performed.

Results: 413 critically ill patients with SARS-CoV-2-induced ARDS were analyzed. Patients who did not survive had significantly higher NRBC values during their ICU stay compared to patients who survived (1090/µl [310; 3883] vs. 140/µl [20; 500]; p < 0.0001). Patients with severe ARDS (n = 374) had significantly higher NRBC values during ICU stay compared to patients with moderate ARDS (n = 38) (490/µl [120; 1890] vs. 30/µl [10; 476]; p < 0.0001). A cut-off level of NRBC ≥ 500/µl was found to best stratify risk and was associated with a longer duration of ICU stay (12 [8; 18] vs. 18 [13; 27] days; p < 0.0001) and longer duration of mechanical ventilation (10 [6; 16] vs. 17 [12; 26] days; p < 0.0001). Logistic regression analysis with multivariate adjustment showed NRBCs ≥ 500/µl to be an independent risk factor of mortality (odds ratio (OR) 4.72; 95% confidence interval (CI) 2.95-7.62, p < 0.0001). Patients with NRBC values below the threshold of 500/µl had a significant survival advantage over those above the threshold (median survival 32 [95% CI 8.7-43.3] vs. 21 days [95% CI 18.2-23.8], log-rank test, p < 0.05). Patients who once reached the NRBC threshold of ≥ 500/µl during their ICU stay had a significantly increased long-term mortality (median survival 489 days, log-rank test, p = 0.0029, hazard ratio (HR) 3.2, 95% CI 1.2-8.5).

Conclusions: NRBCs predict mortality in critically ill patients with SARS-CoV-2-induced ARDS with high prognostic power. Further studies are required to confirm the clinical impact of NRBCs to eventually enhance decision making.

背景:重症患者外周血中出现有核红细胞(NRBC)与预后不良有关。有关 NRBC 在由 SARS-CoV-2 引起的急性呼吸窘迫综合征(ARDS)患者中的预测价值的证据仍不明确。本研究旨在评估 NRBC 在这些患者中的预测有效性:方法:评估了 SARS-CoV-2 诱导的 ARDS 成年患者的每日 NRBC 值,并对其预测死亡率的有效性进行了统计评估。根据患者在重症监护室住院期间的 NRBC 最大值计算出一个临界值,并根据尤登方法进一步确定。在此临界值的基础上,进一步进行了逻辑回归模型和存活率等分析:结果:分析了 413 例 SARS-CoV-2 引起的 ARDS 重症患者。与存活患者相比,未存活患者在重症监护室住院期间的 NRBC 值明显更高(1090/µl [310; 3883] vs. 140/µl [20; 500]; p 结论:NRBC 可预测重症患者的死亡率:NRBC 可预测 SARS-CoV-2 引起的 ARDS 重症患者的死亡率,预后能力很强。需要进一步的研究来证实 NRBCs 的临床影响,以最终提高决策水平。
{"title":"Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study.","authors":"Anna Kirsch, Felix Niebhagen, Miriam Goldammer, Sandra Waske, Lars Heubner, Paul Petrick, Andreas Güldner, Thea Koch, Peter Spieth, Mario Menk","doi":"10.1186/s44158-024-00174-2","DOIUrl":"10.1186/s44158-024-00174-2","url":null,"abstract":"<p><strong>Background: </strong>The presence of nucleated red blood cells (NRBCs) in the peripheral blood of critically ill patients is associated with poor outcome. Evidence regarding the predictive value of NRBCs in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) remains elusive. The aim of this study was to evaluate the predictive validity of NRBCs in these patients.</p><p><strong>Methods: </strong>Daily NRBC values of adult patients with SARS-CoV-2-induced ARDS were assessed and their predictive validity for mortality was statistically evaluated. A cut-off level based on the patient's maximum NRBC value during ICU stay was calculated and further specified according to Youden's method. Based on this cut-off value, further analyses such as logistic regression models and survival were performed.</p><p><strong>Results: </strong>413 critically ill patients with SARS-CoV-2-induced ARDS were analyzed. Patients who did not survive had significantly higher NRBC values during their ICU stay compared to patients who survived (1090/µl [310; 3883] vs. 140/µl [20; 500]; p < 0.0001). Patients with severe ARDS (n = 374) had significantly higher NRBC values during ICU stay compared to patients with moderate ARDS (n = 38) (490/µl [120; 1890] vs. 30/µl [10; 476]; p < 0.0001). A cut-off level of NRBC ≥ 500/µl was found to best stratify risk and was associated with a longer duration of ICU stay (12 [8; 18] vs. 18 [13; 27] days; p < 0.0001) and longer duration of mechanical ventilation (10 [6; 16] vs. 17 [12; 26] days; p < 0.0001). Logistic regression analysis with multivariate adjustment showed NRBCs ≥ 500/µl to be an independent risk factor of mortality (odds ratio (OR) 4.72; 95% confidence interval (CI) 2.95-7.62, p < 0.0001). Patients with NRBC values below the threshold of 500/µl had a significant survival advantage over those above the threshold (median survival 32 [95% CI 8.7-43.3] vs. 21 days [95% CI 18.2-23.8], log-rank test, p < 0.05). Patients who once reached the NRBC threshold of ≥ 500/µl during their ICU stay had a significantly increased long-term mortality (median survival 489 days, log-rank test, p = 0.0029, hazard ratio (HR) 3.2, 95% CI 1.2-8.5).</p><p><strong>Conclusions: </strong>NRBCs predict mortality in critically ill patients with SARS-CoV-2-induced ARDS with high prognostic power. Further studies are required to confirm the clinical impact of NRBCs to eventually enhance decision making.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11212412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of high-flow nasal cannula at different flow rates on diaphragmatic function in subjects recovering from an acute exacerbation of COPD: a physiological prospective pilot study. 不同流速的高流量鼻插管对慢性阻塞性肺病急性加重恢复期患者膈肌功能的影响:一项生理学前瞻性试验研究。
Pub Date : 2024-06-24 DOI: 10.1186/s44158-024-00173-3
Nicolás Colaianni-Alfonso, Iván Castro, Vanesa Cáceres, Guillermo Montiel, Salvatore Maurizio Maggiore, Luigi Vetrugno

Background: Noninvasive ventilation (NIV) is widely employed as the initial treatment for patients with chronic acute exacerbation of obstructive pulmonary disease (AECOPD). Nevertheless, high-flow nasal cannula (HFNC) has been increasingly utilized and investigated to mitigate the issues associated with NIV. Flow rate may play a significant role in diaphragmatic function among subjects recovering from AECOPD. Based on these observations, we conducted a physiological study to assess the impact of HFNC therapy on diaphragmatic function, as measured by US, respiratory rate (RR), gas exchange, and patient comfort at various flow rates.

Methods: A prospective physiological pilot study enrolled subjects with a diagnosis of AECOPD who required NIV for more than 24 h. After stabilization, these subjects underwent a 30-min trial using NIV and HFNC at different sequential flow rates (30-60 L/min). At the end of each trial, diaphragmatic displacement (DD, cm) and diaphragmatic thickness fraction (DTF, %) were measured using ultrasound. Additionally, other physiological variables, such as RR, gas exchange, and patient comfort, were recorded.

Results: A total of 20 patients were included in the study. DD was no different among trials (p = 0.753). DTF (%) was significantly lower with HFNC-30 L/min compared to HFNC-50 and 60 L/min (p < 0.001 for all comparisons). No significant differences were found in arterial pH and PaCO2 at discontinuation of NIV and at the end of HFNC trials (p > 0.050). During HFNC trials, RR remained unchanged without statistically significant differences (p = 0.611). However, we observed that HFNC improved comfort compared to NIV (p < 0.001 for all comparisons). Interestingly, HFNC at 30 and 40 L/min showed greater comfort during trials.

Conclusions: In subjects recovering from AECOPD and receiving HFNC, flows above 40 L/min may not offer additional benefits in terms of comfort and decreased respiratory effort. HFNC could be a suitable alternative to COT during breaks off NIV.

背景:无创通气(NIV)被广泛用作慢性阻塞性肺疾病(AECOPD)急性加重患者的初始治疗方法。然而,高流量鼻插管(HFNC)的使用和研究越来越多,以缓解与 NIV 相关的问题。流速可能对 AECOPD 康复者的膈肌功能起着重要作用。基于这些观察结果,我们进行了一项生理学研究,以评估 HFNC 治疗对膈肌功能的影响(通过 US、呼吸频率 (RR)、气体交换和患者在不同流速下的舒适度进行测量):在病情稳定后,这些受试者接受了 30 分钟的 NIV 和不同顺序流速(30-60 升/分钟)的 HFNC 试验。在每次试验结束时,使用超声波测量膈肌位移(DD,cm)和膈肌厚度分数(DTF,%)。此外,还记录了其他生理变量,如呼吸频率、气体交换和患者舒适度:研究共纳入了 20 名患者。各试验的 DD 无差异(p = 0.753)。与 HFNC-50 和 60 L/min 相比,HFNC-30 L/min 的 DTF(%)明显较低(p aCO2 在 NIV 停止时和 HFNC 试验结束时(p > 0.050)。在 HFNC 试验期间,RR 保持不变,无显著统计学差异(p = 0.611)。不过,我们观察到,与 NIV 相比,HFNC 改善了舒适度(p 结论:HFNC 改善了舒适度:对于从 AECOPD 恢复并接受 HFNC 的受试者,流量超过 40 升/分钟可能不会在舒适度和减少呼吸努力方面带来额外的益处。在 NIV 中断期间,HFNC 可以作为 COT 的合适替代品。
{"title":"Effect of high-flow nasal cannula at different flow rates on diaphragmatic function in subjects recovering from an acute exacerbation of COPD: a physiological prospective pilot study.","authors":"Nicolás Colaianni-Alfonso, Iván Castro, Vanesa Cáceres, Guillermo Montiel, Salvatore Maurizio Maggiore, Luigi Vetrugno","doi":"10.1186/s44158-024-00173-3","DOIUrl":"10.1186/s44158-024-00173-3","url":null,"abstract":"<p><strong>Background: </strong>Noninvasive ventilation (NIV) is widely employed as the initial treatment for patients with chronic acute exacerbation of obstructive pulmonary disease (AECOPD). Nevertheless, high-flow nasal cannula (HFNC) has been increasingly utilized and investigated to mitigate the issues associated with NIV. Flow rate may play a significant role in diaphragmatic function among subjects recovering from AECOPD. Based on these observations, we conducted a physiological study to assess the impact of HFNC therapy on diaphragmatic function, as measured by US, respiratory rate (RR), gas exchange, and patient comfort at various flow rates.</p><p><strong>Methods: </strong>A prospective physiological pilot study enrolled subjects with a diagnosis of AECOPD who required NIV for more than 24 h. After stabilization, these subjects underwent a 30-min trial using NIV and HFNC at different sequential flow rates (30-60 L/min). At the end of each trial, diaphragmatic displacement (DD, cm) and diaphragmatic thickness fraction (DTF, %) were measured using ultrasound. Additionally, other physiological variables, such as RR, gas exchange, and patient comfort, were recorded.</p><p><strong>Results: </strong>A total of 20 patients were included in the study. DD was no different among trials (p = 0.753). DTF (%) was significantly lower with HFNC-30 L/min compared to HFNC-50 and 60 L/min (p < 0.001 for all comparisons). No significant differences were found in arterial pH and P<sub>a</sub>CO<sub>2</sub> at discontinuation of NIV and at the end of HFNC trials (p > 0.050). During HFNC trials, RR remained unchanged without statistically significant differences (p = 0.611). However, we observed that HFNC improved comfort compared to NIV (p < 0.001 for all comparisons). Interestingly, HFNC at 30 and 40 L/min showed greater comfort during trials.</p><p><strong>Conclusions: </strong>In subjects recovering from AECOPD and receiving HFNC, flows above 40 L/min may not offer additional benefits in terms of comfort and decreased respiratory effort. HFNC could be a suitable alternative to COT during breaks off NIV.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11197175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141447714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maladaptive personality traits are associated with burnout risk in Italian anesthesiologists and intensivists: a secondary analysis from a cross-sectional study. 适应不良的人格特质与意大利麻醉师和重症监护医师的职业倦怠风险有关:一项横断面研究的二次分析。
Pub Date : 2024-06-21 DOI: 10.1186/s44158-024-00171-5
Alessandro Vittori, Emiliano Petrucci, Marco Cascella, Elena Giovanna Bignami, Alessandro Simonini, Giacomo Sollecchia, Gilberto Fiore, Alessandro Vergallo, Franco Marinangeli, Roberto Pedone

Background: Burnout is a maladaptive response to chronic stress, particularly prevalent among clinicians. Anesthesiologists are at risk of burnout, but the role of maladaptive traits in their vulnerability to burnout remains understudied.

Methods: A secondary analysis was performed on data from the Italian Association of Hospital Anesthesiologists, Pain Medicine Specialists, Critical Care, and Emergency (AAROI-EMAC) physicians. The survey included demographic data, burnout assessment using the Maslach Burnout Inventory (MBI) and subscales (emotional exhaustion, MBI-EE; depersonalization, MBI-DP; personal accomplishment, MBI-PA), and evaluation of personality disorders (PDs) based on DSM-IV (Diagnostic and Statistical Manual of Mental Disorders Fourth Edition) criteria using the assessment of DSM-IV PDs (ADP-IV). We investigated the aggregated scores of maladaptive personality traits as predictor variables of burnout. Subsequently, the components of personality traits were individually assessed.

Results: Out of 310 respondents, 300 (96.77%) provided complete information. The maladaptive personality traits global score was associated with the MBI-EE and MBI-DP components. There was a significant negative correlation with the MBI-PA component. Significant positive correlations were found between the MBI-EE subscale and the paranoid (r = 0.42), borderline (r = 0.39), and dependent (r = 0.39) maladaptive personality traits. MBI-DP was significantly associated with the passive-aggressive (r = 0.35), borderline (r = 0.33), and avoidant (r = 0.32) traits. Moreover, MBI-PA was negatively associated with dependent (r =  - 0.26) and avoidant (r =  - 0.25) maladaptive personality features.

Conclusions: There is a significant association between different maladaptive personality traits and the risk of experiencing burnout among anesthesiologists. This underscores the importance of understanding and addressing personality traits in healthcare professionals to promote their well-being and prevent this serious emotional, mental, and physical exhaustion state.

背景:职业倦怠是对长期压力的一种不适应反应,在临床医生中尤为普遍。麻醉科医生有职业倦怠的风险,但适应不良特质在其职业倦怠脆弱性中所起的作用仍未得到充分研究:对意大利医院麻醉科、疼痛科、重症监护和急诊科医师协会(AAROI-EMAC)的数据进行了二次分析。调查内容包括人口统计学数据、使用马斯拉赫职业倦怠量表(Maslach Burnout Inventory,MBI)和分量表(情感衰竭,MBI-EE;人格解体,MBI-DP;个人成就感,MBI-PA)进行的职业倦怠评估,以及根据DSM-IV(《精神疾病诊断与统计手册》第四版)标准使用DSM-IV人格障碍评估(ADP-IV)进行的人格障碍评估。我们研究了作为职业倦怠预测变量的适应不良人格特质的总分。随后,我们对人格特质的各个组成部分进行了单独评估:在 310 名受访者中,有 300 人(96.77%)提供了完整的信息。适应不良型人格特征的总分与 MBI-EE 和 MBI-DP 成分相关。与 MBI-PA 部分呈显著负相关。MBI-EE分量表与偏执型人格特质(r = 0.42)、边缘型人格特质(r = 0.39)和依赖型人格特质(r = 0.39)呈显著正相关。MBI-DP与被动攻击型(r = 0.35)、边缘型(r = 0.33)和回避型(r = 0.32)人格特质有明显相关。此外,MBI-PA 与依赖型(r = - 0.26)和回避型(r = - 0.25)适应不良人格特征呈负相关:结论:不同的适应不良型人格特质与麻醉医师出现职业倦怠的风险之间存在明显关联。这强调了了解和解决医护人员人格特质的重要性,以促进他们的福祉,防止这种严重的情绪、精神和身体疲惫状态。
{"title":"Maladaptive personality traits are associated with burnout risk in Italian anesthesiologists and intensivists: a secondary analysis from a cross-sectional study.","authors":"Alessandro Vittori, Emiliano Petrucci, Marco Cascella, Elena Giovanna Bignami, Alessandro Simonini, Giacomo Sollecchia, Gilberto Fiore, Alessandro Vergallo, Franco Marinangeli, Roberto Pedone","doi":"10.1186/s44158-024-00171-5","DOIUrl":"10.1186/s44158-024-00171-5","url":null,"abstract":"<p><strong>Background: </strong>Burnout is a maladaptive response to chronic stress, particularly prevalent among clinicians. Anesthesiologists are at risk of burnout, but the role of maladaptive traits in their vulnerability to burnout remains understudied.</p><p><strong>Methods: </strong>A secondary analysis was performed on data from the Italian Association of Hospital Anesthesiologists, Pain Medicine Specialists, Critical Care, and Emergency (AAROI-EMAC) physicians. The survey included demographic data, burnout assessment using the Maslach Burnout Inventory (MBI) and subscales (emotional exhaustion, MBI-EE; depersonalization, MBI-DP; personal accomplishment, MBI-PA), and evaluation of personality disorders (PDs) based on DSM-IV (Diagnostic and Statistical Manual of Mental Disorders Fourth Edition) criteria using the assessment of DSM-IV PDs (ADP-IV). We investigated the aggregated scores of maladaptive personality traits as predictor variables of burnout. Subsequently, the components of personality traits were individually assessed.</p><p><strong>Results: </strong>Out of 310 respondents, 300 (96.77%) provided complete information. The maladaptive personality traits global score was associated with the MBI-EE and MBI-DP components. There was a significant negative correlation with the MBI-PA component. Significant positive correlations were found between the MBI-EE subscale and the paranoid (r = 0.42), borderline (r = 0.39), and dependent (r = 0.39) maladaptive personality traits. MBI-DP was significantly associated with the passive-aggressive (r = 0.35), borderline (r = 0.33), and avoidant (r = 0.32) traits. Moreover, MBI-PA was negatively associated with dependent (r =  - 0.26) and avoidant (r =  - 0.25) maladaptive personality features.</p><p><strong>Conclusions: </strong>There is a significant association between different maladaptive personality traits and the risk of experiencing burnout among anesthesiologists. This underscores the importance of understanding and addressing personality traits in healthcare professionals to promote their well-being and prevent this serious emotional, mental, and physical exhaustion state.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The new neural pressure support (NPS) mode and the helmet: did we find the dynamic duo? 新的神经压力支持(NPS)模式和头盔:我们是否找到了动态二重奏?
Pub Date : 2024-06-10 DOI: 10.1186/s44158-024-00170-6
Alessandro Costa, Federico Merlo, Aline Pagni, Paolo Navalesi, Giacomo Grasselli, Gianmaria Cammarota, Davide Colombo

Background: Noninvasive ventilation (NIV) is commonly used in clinical practice to reduce intubation times and enhance patient comfort. However, patient-ventilator interaction (PVI) during NIV, particularly with helmet interfaces, can be challenging due to factors such as dead space and compliance. Neurally adjusted ventilatory assist (NAVA) has shown promise in improving PVI during helmet NIV, but limitations remain. A new mode, neural pressure support (NPS), aims to address these limitations by providing synchronized and steep pressurization. This study aims to assess whether NPS per se improves PVI during helmet NIV compared to standard pressure support ventilation (PSV).

Methods: The study included adult patients requiring NIV with a helmet. Patients were randomized into two arms: one starting with NPS and the other with PSV; the initial ventilatory parameters were always set as established by the clinician on duty. Physiological parameters and arterial blood gas analysis were collected during ventilation trials. Expert adjustments to initial ventilator settings were recorded to investigate the impact of the expertise of the clinician as confounding variable. Primary aim was the synchrony time (Timesync), i.e., the time during which both the ventilator and the patient (based on the neural signal) are on the inspiratory phase. As secondary aim neural-ventilatory time index (NVTI) was also calculated as Timesync divided to the total neural inspiratory time, i.e., the ratio of the neural inspiratory time occupied by Timesync.

Results: Twenty-four patients were enrolled, with no study interruptions due to safety concerns. NPS demonstrated significantly longer Timesync (0.64 ± 0.03 s vs. 0.37 ± 0.03 s, p < 0.001) and shorter inspiratory delay (0.15 ± 0.01 s vs. 0.35 ± 0.01 s, p < 0.001) compared to PSV. NPS also showed better NVTI (78 ± 2% vs. 45 ± 2%, p < 0.001). Ventilator parameters were not significantly different between NPS and PSV, except for minor adjustments by the expert clinician.

Conclusions: NPS improves PVI during helmet NIV, as evidenced by longer Timesync and better coupling compared to PSV. Expert adjustments to ventilator settings had minimal impact on PVI. These findings support the use of NPS in enhancing patient-ventilator synchronization and warrant further investigation into its clinical outcomes and applicability across different patient populations and interfaces.

Trial registration: This study was registered on www.

Clinicaltrials: gov NCT06004206 Registry URL: https://clinicaltrials.gov/study/NCT06004206 on September 08, 2023.

背景:无创通气(NIV)通常用于临床实践,以缩短插管时间并提高患者舒适度。然而,由于死腔和顺应性等因素,无创通气过程中患者与呼吸机的交互(PVI),尤其是头盔接口,可能具有挑战性。神经调节通气辅助(NAVA)在改善头盔 NIV 期间的 PVI 方面已显示出前景,但仍存在局限性。神经压力支持(NPS)是一种新模式,旨在通过提供同步和陡峭的加压来解决这些局限性。本研究旨在评估与标准压力支持通气(PSV)相比,神经压力支持本身是否能改善头盔 NIV 期间的 PVI:研究对象包括需要使用头盔进行 NIV 的成年患者。患者被随机分为两组:一组从 NPS 开始,另一组从 PSV 开始;初始通气参数始终由值班临床医生设定。通气试验期间收集生理参数和动脉血气分析。记录专家对初始呼吸机设置的调整,以研究临床医生的专业知识作为混杂变量的影响。主要目标是同步时间(Timesync),即呼吸机和患者(基于神经信号)都处于吸气阶段的时间。作为次要目标,神经通气时间指数(NVTI)的计算方法也是 Timesync 除以神经吸气总时间,即 Timesync 所占神经吸气时间的比率:共有 24 名患者入选,没有人因安全问题中断研究。NPS 明显延长了 Timesync 时间(0.64±0.03 秒 vs. 0.37±0.03 秒,p I(78±2% vs. 45±2%,p 结论:NPS 改善了头盔呼吸过程中的 PVI:与 PSV 相比,NPS 可通过更长的 Timesync 和更好的耦合改善头盔 NIV 期间的 PVI。专家对呼吸机设置的调整对 PVI 的影响微乎其微。这些发现支持使用 NPS 提高患者与呼吸机的同步性,值得进一步研究其临床效果以及在不同患者群体和界面中的适用性:本研究于 2023 年 9 月 8 日在 www.Clinicaltrials: gov NCT06004206 注册,注册网址:https://clinicaltrials.gov/study/NCT06004206。
{"title":"The new neural pressure support (NPS) mode and the helmet: did we find the dynamic duo?","authors":"Alessandro Costa, Federico Merlo, Aline Pagni, Paolo Navalesi, Giacomo Grasselli, Gianmaria Cammarota, Davide Colombo","doi":"10.1186/s44158-024-00170-6","DOIUrl":"10.1186/s44158-024-00170-6","url":null,"abstract":"<p><strong>Background: </strong>Noninvasive ventilation (NIV) is commonly used in clinical practice to reduce intubation times and enhance patient comfort. However, patient-ventilator interaction (PVI) during NIV, particularly with helmet interfaces, can be challenging due to factors such as dead space and compliance. Neurally adjusted ventilatory assist (NAVA) has shown promise in improving PVI during helmet NIV, but limitations remain. A new mode, neural pressure support (NPS), aims to address these limitations by providing synchronized and steep pressurization. This study aims to assess whether NPS per se improves PVI during helmet NIV compared to standard pressure support ventilation (PSV).</p><p><strong>Methods: </strong>The study included adult patients requiring NIV with a helmet. Patients were randomized into two arms: one starting with NPS and the other with PSV; the initial ventilatory parameters were always set as established by the clinician on duty. Physiological parameters and arterial blood gas analysis were collected during ventilation trials. Expert adjustments to initial ventilator settings were recorded to investigate the impact of the expertise of the clinician as confounding variable. Primary aim was the synchrony time (Time<sub>sync</sub>), i.e., the time during which both the ventilator and the patient (based on the neural signal) are on the inspiratory phase. As secondary aim neural-ventilatory time index (NVT<sub>I</sub>) was also calculated as Time<sub>sync</sub> divided to the total neural inspiratory time, i.e., the ratio of the neural inspiratory time occupied by Time<sub>sync</sub>.</p><p><strong>Results: </strong>Twenty-four patients were enrolled, with no study interruptions due to safety concerns. NPS demonstrated significantly longer Time<sub>sync</sub> (0.64 ± 0.03 s vs. 0.37 ± 0.03 s, p < 0.001) and shorter inspiratory delay (0.15 ± 0.01 s vs. 0.35 ± 0.01 s, p < 0.001) compared to PSV. NPS also showed better NVT<sub>I</sub> (78 ± 2% vs. 45 ± 2%, p < 0.001). Ventilator parameters were not significantly different between NPS and PSV, except for minor adjustments by the expert clinician.</p><p><strong>Conclusions: </strong>NPS improves PVI during helmet NIV, as evidenced by longer Time<sub>sync</sub> and better coupling compared to PSV. Expert adjustments to ventilator settings had minimal impact on PVI. These findings support the use of NPS in enhancing patient-ventilator synchronization and warrant further investigation into its clinical outcomes and applicability across different patient populations and interfaces.</p><p><strong>Trial registration: </strong>This study was registered on www.</p><p><strong>Clinicaltrials: </strong>gov NCT06004206 Registry URL: https://clinicaltrials.gov/study/NCT06004206 on September 08, 2023.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141302273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in telemedicine implementation for preoperative assessment: a call to action. 远程医疗在术前评估中的应用进展:行动呼吁。
Pub Date : 2024-06-05 DOI: 10.1186/s44158-024-00172-4
Elena Giovanna Bignami, Michele Berdini, Matteo Panizzi, Valentina Bellini
{"title":"Advances in telemedicine implementation for preoperative assessment: a call to action.","authors":"Elena Giovanna Bignami, Michele Berdini, Matteo Panizzi, Valentina Bellini","doi":"10.1186/s44158-024-00172-4","DOIUrl":"10.1186/s44158-024-00172-4","url":null,"abstract":"","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141249102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson's disease. 基底神经节中内源性大麻素与多巴胺之间的相互作用:对帕金森病疼痛的影响。
Pub Date : 2024-05-14 DOI: 10.1186/s44158-024-00169-z
Maria Mancini, Alessandra Calculli, Deborah Di Martino, Antonio Pisani

Pain is a complex phenomenon, and basal ganglia circuitry integrates many aspects of pain including motor, emotional, autonomic, and cognitive responses. Perturbations in dopamine (DA) signaling are implicated in the pathogenesis of chronic pain due to its involvement in both pain perception and relief. Several lines of evidence support the role of endocannabinoids (eCBs) in the regulation of many electrical and chemical aspects of DAergic neuron function including excitability, synaptic transmission, integration, and plasticity. However, eCBs play an even more intricate and intimate relationship with DA, as indicated by the adaptive changes in the eCB system following DA depletion. Although the precise mechanisms underlying DA control on pain are not fully understood, given the high correlation of eCB and DAergic system, it is conceivable that eCBs may be part of these mechanisms.In this brief survey, we describe the reciprocal regulation of eCB-DA neurotransmission with a particular emphasis on the actions of eCBs on ionic and synaptic signaling in DAergic neurons mediated by CB receptors or independent on them. Furthermore, we analyze the eCB-DA imbalance which characterizes pain condition and report the implications of reduced DA levels for pain in Parkinson's disease. Lastly, we discuss the potential of the eCB-DA system in the development of future therapeutic strategies for the treatment of pain.

疼痛是一种复杂的现象,基底神经节回路整合了疼痛的许多方面,包括运动、情绪、自主神经和认知反应。多巴胺(DA)信号的干扰与慢性疼痛的发病机制有关,因为多巴胺参与了疼痛的感知和缓解。多种证据表明,内源性大麻素(eCBs)在调节多巴胺能神经元功能的许多电学和化学方面发挥作用,包括兴奋性、突触传递、整合和可塑性。然而,eCBs 与 DA 的关系更为复杂和密切,这一点从 DA 耗尽后 eCB 系统的适应性变化可以看出。在这篇简短的文章中,我们描述了 eCB-DA 神经传递的相互调节,特别强调了 eCB 对由 CB 受体介导或独立于 CB 受体的 DA 能神经元离子和突触信号传递的作用。此外,我们还分析了作为疼痛特征的 eCB-DA 失衡,并报告了 DA 水平降低对帕金森病疼痛的影响。最后,我们讨论了 eCB-DA 系统在开发未来疼痛治疗策略方面的潜力。
{"title":"Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson's disease.","authors":"Maria Mancini, Alessandra Calculli, Deborah Di Martino, Antonio Pisani","doi":"10.1186/s44158-024-00169-z","DOIUrl":"10.1186/s44158-024-00169-z","url":null,"abstract":"<p><p>Pain is a complex phenomenon, and basal ganglia circuitry integrates many aspects of pain including motor, emotional, autonomic, and cognitive responses. Perturbations in dopamine (DA) signaling are implicated in the pathogenesis of chronic pain due to its involvement in both pain perception and relief. Several lines of evidence support the role of endocannabinoids (eCBs) in the regulation of many electrical and chemical aspects of DAergic neuron function including excitability, synaptic transmission, integration, and plasticity. However, eCBs play an even more intricate and intimate relationship with DA, as indicated by the adaptive changes in the eCB system following DA depletion. Although the precise mechanisms underlying DA control on pain are not fully understood, given the high correlation of eCB and DAergic system, it is conceivable that eCBs may be part of these mechanisms.In this brief survey, we describe the reciprocal regulation of eCB-DA neurotransmission with a particular emphasis on the actions of eCBs on ionic and synaptic signaling in DAergic neurons mediated by CB receptors or independent on them. Furthermore, we analyze the eCB-DA imbalance which characterizes pain condition and report the implications of reduced DA levels for pain in Parkinson's disease. Lastly, we discuss the potential of the eCB-DA system in the development of future therapeutic strategies for the treatment of pain.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11094869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140923942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcome of COVID-19 patients with acute kidney injury requiring kidney replacement therapy. COVID-19 急性肾损伤患者需要肾脏替代疗法的长期疗效。
Pub Date : 2024-05-09 DOI: 10.1186/s44158-024-00163-5
Ilaria Godi, Laura Pasin, Andrea Ballin, Gabriele Martelli, Claudio Bonanno, Francesco Terranova, Enrico Tamburini, Caterina Simoni, Ginevra Randon, Nicola Franchetti, Leda Cattarin, Federico Nalesso, Lorenzo Calò, Ivo Tiberio

Background: Limited data existed on the burden of coronavirus disease 2019 (COVID-19) renal complications and the outcomes of the most critical patients who required kidney replacement therapy (KRT) during intensive care unit (ICU) stay. We aimed to describe mortality and renal function at 90 days in patients admitted for COVID-19 and KRT.

Methods: A retrospective cohort study of critically ill patients admitted for COVID-19 and requiring KRT from March 2020 to January 2022 was conducted in an Italian ICU from a tertiary care hospital. Primary outcome was mortality at 90 days and secondary outcome was kidney function at 90 days.

Results: A cohort of 45 patients was analyzed. Mortality was 60% during ICU stay and increased from 64% at the time of hospital discharge to 71% at 90 days. Among 90-day survivors, 31% required dialysis, 38% recovered incompletely, and 31% completely recovered renal function. The probability of being alive and dialysis-free at 3 months was 22%.

Conclusions: Critically ill patients with COVID-19 disease requiring KRT during ICU stay had elevated mortality rate at 90 days, with low probability of being alive and dialysis-free at 3 months. However, a non-negligible number of patients completely recovered renal function.

背景:关于2019年冠状病毒病(COVID-19)肾脏并发症的负担以及在重症监护室(ICU)住院期间需要肾脏替代治疗(KRT)的最危重患者的预后的数据有限。我们旨在描述因COVID-19和KRT入院的患者90天后的死亡率和肾功能:我们在意大利一家三级医院的重症监护病房对 2020 年 3 月至 2022 年 1 月期间因 COVID-19 入院并需要 KRT 的重症患者进行了一项回顾性队列研究。主要结果是 90 天的死亡率,次要结果是 90 天的肾功能:结果:分析了 45 名患者。在重症监护室住院期间,死亡率为 60%,出院时为 64%,90 天后增至 71%。在90天存活的患者中,31%需要透析,38%不完全恢复,31%完全恢复了肾功能。3个月后存活且无需透析的概率为22%:结论:COVID-19 重症患者在重症监护室住院期间需要接受 KRT 治疗,90 天后死亡率较高,3 个月后存活和无透析的概率较低。但也有相当数量的患者完全恢复了肾功能。
{"title":"Long-term outcome of COVID-19 patients with acute kidney injury requiring kidney replacement therapy.","authors":"Ilaria Godi, Laura Pasin, Andrea Ballin, Gabriele Martelli, Claudio Bonanno, Francesco Terranova, Enrico Tamburini, Caterina Simoni, Ginevra Randon, Nicola Franchetti, Leda Cattarin, Federico Nalesso, Lorenzo Calò, Ivo Tiberio","doi":"10.1186/s44158-024-00163-5","DOIUrl":"10.1186/s44158-024-00163-5","url":null,"abstract":"<p><strong>Background: </strong>Limited data existed on the burden of coronavirus disease 2019 (COVID-19) renal complications and the outcomes of the most critical patients who required kidney replacement therapy (KRT) during intensive care unit (ICU) stay. We aimed to describe mortality and renal function at 90 days in patients admitted for COVID-19 and KRT.</p><p><strong>Methods: </strong>A retrospective cohort study of critically ill patients admitted for COVID-19 and requiring KRT from March 2020 to January 2022 was conducted in an Italian ICU from a tertiary care hospital. Primary outcome was mortality at 90 days and secondary outcome was kidney function at 90 days.</p><p><strong>Results: </strong>A cohort of 45 patients was analyzed. Mortality was 60% during ICU stay and increased from 64% at the time of hospital discharge to 71% at 90 days. Among 90-day survivors, 31% required dialysis, 38% recovered incompletely, and 31% completely recovered renal function. The probability of being alive and dialysis-free at 3 months was 22%.</p><p><strong>Conclusions: </strong>Critically ill patients with COVID-19 disease requiring KRT during ICU stay had elevated mortality rate at 90 days, with low probability of being alive and dialysis-free at 3 months. However, a non-negligible number of patients completely recovered renal function.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11083751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of intercostal muscles contraction on sonographic evaluation of lung sliding: a physiological study on healthy subjects. 肋间肌收缩对肺滑动声学评估的影响:对健康人的生理学研究。
Pub Date : 2024-05-06 DOI: 10.1186/s44158-024-00168-0
Daniele Guerino Biasucci, Alessandro Cina, Claudio Sandroni, Umberto Moscato, Mario Dauri, Luigi Vetrugno, Franco Cavaliere

Objectives: To investigate the following: (a) effects of intercostal muscle contraction on sonographic assessment of lung sliding and (b) inter-rater and intra-observer agreement on sonographic detection of lung sliding and lung pulse.

Methods: We used Valsalva and Muller maneuvers as experimental models in which closed glottis and clipped nose prevent air from entering the lungs, despite sustained intercostal muscles contraction. Twenty-one healthy volunteers underwent bilateral lung ultrasound during tidal breathing, apnea, hyperventilation, and Muller and Valsalva maneuvers. The same expert recorded 420 B-mode clips and 420 M-mode images, independently evaluated for the presence or absence of lung sliding and lung pulse by three raters unaware of the respiratory activity corresponding to each imaging.

Results: During Muller and Valsalva maneuvers, lung sliding was certainly recognized in up to 73.0% and up to 68.7% of imaging, respectively, with a slight to fair inter-rater agreement for Muller maneuver and slight to moderate for Valsalva. Lung sliding was unrecognized in up to 42.0% of tidal breathing imaging, and up to 12.5% of hyperventilation imaging, with a slight to fair inter-rater agreement for both. During apnea, interpretation errors for sliding were irrelevant and inter-rater agreement moderate to perfect. Even if intra-observer agreement varied among raters and throughout respiratory patterns, we found it to be higher than inter-rater reliability.

Conclusions: Intercostal muscles contraction produces sonographic artifacts that may simulate lung sliding. Clinical studies are needed to confirm this hypothesis. We found slight to moderate inter-rater agreement and globally moderate to almost perfect intra-observer agreement for lung sliding and lung pulse.

Trial registration: ClinicalTrials.gov registration number. NCT02386696.

目标:研究以下内容:(a) 肋间肌收缩对肺滑动声像图评估的影响;(b) 观察者之间和观察者内部对肺滑动和肺脉搏声像图检测的一致性:我们使用 Valsalva 和 Muller 动作作为实验模型,在这些模型中,尽管肋间肌持续收缩,但闭合的声门和夹住的鼻子会阻止空气进入肺部。21 名健康志愿者在潮式呼吸、呼吸暂停、过度通气以及穆勒和瓦尔萨尔瓦动作时接受了双侧肺部超声波检查。同一专家记录了 420 个 B 型片段和 420 个 M 型图像,由三名不了解每次成像对应的呼吸活动的评分者独立评估是否存在肺滑动和肺脉冲:在 Muller 和 Valsalva 操作过程中,分别有高达 73.0% 和 68.7% 的成像可确定识别出肺滑动。高达 42.0% 的潮式呼吸成像和高达 12.5% 的过度通气成像未识别出肺滑动,两者的评分者间一致性为轻微到一般。在呼吸暂停期间,滑动的判读误差无关紧要,评分者之间的一致性中等至完美。即使在不同评分者和不同呼吸模式下,观察者内部的一致性有所不同,但我们发现它比评分者之间的可靠性更高:结论:肋间肌收缩产生的声像图伪影可能会模拟肺滑动。临床研究需要证实这一假设。我们发现,在肺滑动和肺脉搏方面,评分者之间的一致性为轻微至中等,观察者内部的一致性为中等至几乎完美:试验注册:ClinicalTrials.gov 注册号:NCT02386696。NCT02386696.
{"title":"Influence of intercostal muscles contraction on sonographic evaluation of lung sliding: a physiological study on healthy subjects.","authors":"Daniele Guerino Biasucci, Alessandro Cina, Claudio Sandroni, Umberto Moscato, Mario Dauri, Luigi Vetrugno, Franco Cavaliere","doi":"10.1186/s44158-024-00168-0","DOIUrl":"10.1186/s44158-024-00168-0","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the following: (a) effects of intercostal muscle contraction on sonographic assessment of lung sliding and (b) inter-rater and intra-observer agreement on sonographic detection of lung sliding and lung pulse.</p><p><strong>Methods: </strong>We used Valsalva and Muller maneuvers as experimental models in which closed glottis and clipped nose prevent air from entering the lungs, despite sustained intercostal muscles contraction. Twenty-one healthy volunteers underwent bilateral lung ultrasound during tidal breathing, apnea, hyperventilation, and Muller and Valsalva maneuvers. The same expert recorded 420 B-mode clips and 420 M-mode images, independently evaluated for the presence or absence of lung sliding and lung pulse by three raters unaware of the respiratory activity corresponding to each imaging.</p><p><strong>Results: </strong>During Muller and Valsalva maneuvers, lung sliding was certainly recognized in up to 73.0% and up to 68.7% of imaging, respectively, with a slight to fair inter-rater agreement for Muller maneuver and slight to moderate for Valsalva. Lung sliding was unrecognized in up to 42.0% of tidal breathing imaging, and up to 12.5% of hyperventilation imaging, with a slight to fair inter-rater agreement for both. During apnea, interpretation errors for sliding were irrelevant and inter-rater agreement moderate to perfect. Even if intra-observer agreement varied among raters and throughout respiratory patterns, we found it to be higher than inter-rater reliability.</p><p><strong>Conclusions: </strong>Intercostal muscles contraction produces sonographic artifacts that may simulate lung sliding. Clinical studies are needed to confirm this hypothesis. We found slight to moderate inter-rater agreement and globally moderate to almost perfect intra-observer agreement for lung sliding and lung pulse.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov registration number. NCT02386696.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Anesthesia, Analgesia and Critical Care (Online)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1